![Ken Ruppel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken Ruppel is currently the Vice President-Scientific & Medical Services at Diaceutics Plc since 2024.
Prior to this, he worked as the Vice President-Precision Medicine at Amplity, Inc.
| Unternehmen | Position | Beginn |
|---|---|---|
| DIACEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Amplity, Inc.
 Amplity, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical & medical outsourcing, infrastructure, consulting and data-driven insights to help clients overcome their medical and commercial challenges | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Amplity, Inc.
Amplity, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical & medical outsourcing, infrastructure, consulting and data-driven insights to help clients overcome their medical and commercial challenges | Commercial Services |
Diaceutics Plc
 Diaceutics Plc BiotechnologyHealth Technology Engages in research and development in medicine drug development and diagnostic tests development | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
